AstraZeneca Announces C$820 Million Investment in Canada
Major expansion to create 700+ jobs and boost Ontario's life sciences sector.
Breaking News
Jan 24, 2025
Mrudula Kulkarni
Image Source: https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.bioprocessintl.com%2Fglobal-markets%2Fastrazeneca-to-build-global-strategic-center-in-shanghai&psig=AOvVaw0m_TT79pRoGEWf9fehwIGP&ust=1737787717192000&source=images&cd=vfe&opi=89978449&ved=0CBQQjRxqFwoTCKC1g_bhjYsDFQAAAAAdAAAAABAE
AstraZeneca, a global leader in pharmaceuticals, has announced a significant C$820 million (US$570 million) investment in Canada. This initiative will generate over 700 high-skilled jobs and support the company’s move to a cutting-edge office facility in Ontario’s Greater Toronto Area.
This investment is part of AstraZeneca’s global strategy to achieve US$80 billion in revenue by 2030 and introduce 20 new medicines worldwide. The company, already one of Canada’s top R&D investors, has contributed over C$1.3 billion to the country’s life sciences sector since 2023. Ontario Premier Doug Ford celebrated the collaboration, highlighting the province’s role as a global life sciences hub, supported by a C$16.1 million investment from the Ontario government through Invest Ontario.
